Cookies

Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Research & Development Medical research, COVID-19

Weathering the Cytokine Storm

A preclinical study showed that administration of THC was highly effective in preventing chemically induced acute respiratory distress syndrome (ARDS) in a mouse model (1).

The researchers exposed mice to enterotoxin B, which usually leads to a cytokine storm that causes the immune system to attack lung tissues. The result? Rapid onset of ARDS and death within a few days. In fact, all of the mice in the untreated control group grew so sick they had to be euthanized.

However, when the researchers gave THC immediately after exposure to the toxin none of the mice developed symptoms of ARDS and 100 percent survived.

These dramatic results have raised speculation that THC might help patients who develop ARDS as a result of COVID-19; however, the research is preliminary at this stage, with no guarantee it will translate from mice to humans.

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Cannabis Scientist site. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

  1. A Mohammed et al., Front Pharmacol, 11, 893 (2020). DOI: 10.3389/fphar.2020.00893

About the Author

Charlotte Barker

Associate Content Director

After studying biology at Imperial College London, I got my start in biomedical publishing as a commissioning editor for healthcare journals, and I’ve spent my career covering everything from early-stage research to clinical medicine. Attracted by the creativity, talent and passion of the team, I joined Texere Publishing in 2014, where I’m now Associate Content Director and Editor of The Cannabis Scientist.

Register to The Cannabis Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Cannabis Scientist magazine

Register